Overcoming rising antibiotic resistance patterns and optimizing eradication rates for chronic gastric ulcers is driving continuous innovation across the Helicobacter pylori Infections Treatment Market. Detailed analysis highlights how potassium-competitive acid blockers (P-CABs) like vonoprazan paired with targeted multi-antibiotic regimens achieve superior first-line bacterial clearance...